D.J.M.has received funding from Sanofi Pasteur (RAB00054 and RAB00055) to conduct the BORS and TRIDL studies  

Colleen Lau is supported by Australian National Health and Medical Research Council (NHMRC) Investigator Grant (APP1193826 ). 

Luis Furuya-Kanamori is supported by an NHMRC Early Career Fellowship (APP1158469)

The funders have no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.